Evolution of epidemiological characteristics of infective endocarditis in Greece.


Journal

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933

Informations de publication

Date de publication:
May 2021
Historique:
received: 06 12 2020
revised: 27 02 2021
accepted: 04 03 2021
pubmed: 13 3 2021
medline: 5 6 2021
entrez: 12 3 2021
Statut: ppublish

Résumé

The clinical profile, management and outcome of infective endocarditis (IE) may be influenced by socioeconomic issues. A nationwide prospective study evaluated IE during the era of deep economic crisis in Greece. Epidemiological data and factors associated with 60-day mortality were analyzed through descriptive statistics, logistic and Cox-regression models. Among 224 patients (male 72.3%, mean age 62.4 years), Staphylococcus aureus (n = 62; methicillin-resistant S. aureus (MRSA) 33.8%) predominated in the young without impact on mortality (p = 0.593), whilst Enterococci (n = 36) predominated in the elderly. Complications of IE were associated with mortality: heart failure [OR 2.415 (95% CI: 1.159-5.029), p = 0.019], stroke [OR 3.206 (95% CI: 1.190-8.632), p = 0.018] and acute kidney injury [OR 2.283 (95% CI: 1.085-4.805), p = 0.029]. A 60-day survival benefit was solely related to cardiac surgery for IE during hospitalization [HR 0.386 (95% CI: 0.165-0.903), p = 0.028] and compliance with antimicrobial treatment guidelines [HR 0.487 (95% CI: 0.259-0.916), p = 0.026]. Compared with a previous country cohort study, history of rheumatic fever and native valve predisposition had declined, whilst underlying renal disease and right-sided IE had increased (p < 0.0001); HIV infection had emerged (p = 0.002). No difference in rates of surgery and outcome was assessed. A country-wide survey of IE highlighted emergence of HIV, right-sided IE and predominance of MRSA in the youth during a severe socioeconomic crisis. Compliance with treatment guidelines promoted survival.

Identifiants

pubmed: 33711517
pii: S1201-9712(21)00226-5
doi: 10.1016/j.ijid.2021.03.009
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

213-220

Investigateurs

Konstantinos Pontikis (K)
Ioannis Lioris (I)
Moysis Lelekis (M)
Athanasios Trikkas (A)
Dimitrios Aggouras (D)
Vasilios Kolias (V)
Chris Rokkas (C)
Maria Nana-Anastasiou (M)
Spiros Miyakis (S)

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Efthymia Giannitsioti (E)

Fourth Department of Internal Medicine, "Attikon" University General Hospital, National and Kapodistrian University of Athens (NKUA), Athens, Greece. Electronic address: gianiemi@hotmail.com.

Angelos Pefanis (A)

Department of Internal Medicine, "Sotiria" Hospital for Chest Diseases, Athens, Greece.

Charalampos Gogos (C)

Department of Internal Medicine, Rio University Hospital, University of Patras, Rio, Greece.

Alexandra Lekkou (A)

Department of Internal Medicine, Rio University Hospital, University of Patras, Rio, Greece.

Georgios N Dalekos (GN)

Department of Internal Medicine, Larissa University Hospital, Faculty of Medicine, University of Thessaly, Larissa, Greece.

Nikolaos Gatselis (N)

Department of Internal Medicine, Larissa University Hospital, Faculty of Medicine, University of Thessaly, Larissa, Greece.

Sara Georgiadou (S)

Department of Internal Medicine, Larissa University Hospital, Faculty of Medicine, University of Thessaly, Larissa, Greece.

Paraskevas Nikou (P)

Department of Internal Medicine, Tripolis General Hospital, Tripolis, Greece.

Agathi Vrettou (A)

Second Department of Cardiology, "Attikon" University General Hospital, NKUA, Athens, Greece.

Angelos Rigopoulos (A)

Second Department of Cardiology, "Attikon" University General Hospital, NKUA, Athens, Greece.

Christos Tryfonopoulos (C)

Department of Informatics and Telecommunications, University of Peloponnese, Tripolis, Greece.

Thomas Tsaganos (T)

Fourth Department of Internal Medicine, "Attikon" University General Hospital, National and Kapodistrian University of Athens (NKUA), Athens, Greece.

Emmanouil Karofilakis (E)

Fourth Department of Internal Medicine, "Attikon" University General Hospital, National and Kapodistrian University of Athens (NKUA), Athens, Greece.

Christos Psarrakis (C)

Fourth Department of Internal Medicine, "Attikon" University General Hospital, National and Kapodistrian University of Athens (NKUA), Athens, Greece.

Michail Argyriou (M)

Cardiosurgical Department "Evangelismos" General Hospital, Athens, Greece.

Panagiotis Gargalianos-Kakolyris (P)

First Department of Internal Medicine, "G. Gennimatas" General Hospital, Athens, Greece.

Georgios Adamis (G)

First Department of Internal Medicine, "G. Gennimatas" General Hospital, Athens, Greece.

Panagiota Lourida (P)

First Department of Internal Medicine, "G. Gennimatas" General Hospital, Athens, Greece.

Diamantis Kofteridis (D)

Department of Internal Medicine, University Hospital of Heraklion, Crete, Greece.

Aggeliki Andrianaki (A)

Department of Internal Medicine, University Hospital of Heraklion, Crete, Greece.

Chariclia Loupa (C)

Department of Internal Medicine, "Amalia Fleming" Hospital, Athens, Greece.

Evangelos Kostis (E)

Department of Clinical Therapeutics, "Alexandra" Hospital, NKUA, Athens, Greece.

Dimitris Sinapidis (D)

Department of Clinical Therapeutics, "Alexandra" Hospital, NKUA, Athens, Greece.

Styliani Sympardi (S)

First Department of Internal Medicine, "Thriassio" General Hospital, Elefsina, Attiki, Greece.

Nikolaos Alexiou (N)

First Department of Internal Medicine, "Thriassio" General Hospital, Elefsina, Attiki, Greece.

Ilias Karaiskos (I)

First Department of Internal Medicine - Infectious Diseases, "Hygeia" Hospital, Athens, Greece.

Aikaterini Masgala (A)

First Department of Internal Medicine, "Agia Olga" Hospital, Athens, Greece.

Efstratios Maltezos (E)

Department of Internal Medicine, University General Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece.

Periklis Panagopoulos (P)

Department of Internal Medicine, University General Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece.

Vasileios Sachpekidis (V)

Second Cardiology Department "Papageorgiou" General Hospital, Aristotele University of Thessaloniki, Thessaloniki, Greece.

Constantinos Evdoridis (C)

Cardiology Department, "Elpis" Hospital, Athens, Greece.

Nikolaos V Sipsas (NV)

Pathophysiology Department, "Laikon" General Hospital of Athens, NKUA, Athens, Greece.

Georgios Daikos (G)

First Department of Internal Medicine, "Laikon "General Hospital of Athens, NKUA, Athens, Greece.

Helen Giamarellou (H)

First Department of Internal Medicine - Infectious Diseases, "Hygeia" Hospital, Athens, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH